|
Varex Imaging Corporation (VREX): Canvas de modèle d'entreprise [Jan-2025 Mise à jour] |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Varex Imaging Corporation (VREX) Bundle
Dans le monde dynamique de la technologie d'imagerie médicale, Varex Imaging Corporation (VREX) est un innovateur pivot, transformant comment les technologies de diagnostic capturent et analysent les informations médicales critiques. En tirant stratégiquement un modèle commercial complet qui couvre l'ingénierie avancée, la fabrication de précision et la recherche de pointe, Vrex s'est positionné comme un catalyseur critique des solutions d'imagerie médicale à travers les écosystèmes mondiaux de soins de santé. Leur approche unique intègre le développement de technologies sophistiqué avec des stratégies de marché ciblées, créant un cadre robuste qui stimule le progrès technologique et répond aux besoins en évolution des professionnels de la santé et des fabricants d'appareils dans le monde entier.
Varex Imaging Corporation (VREX) - Modèle d'entreprise: partenariats clés
Fabricants d'appareils médicaux
Varex Imaging Corporation collabore avec plusieurs fabricants d'appareils médicaux grâce à des partenariats stratégiques.
| Partenaire | Focus de partenariat | Valeur de collaboration |
|---|---|---|
| Siemens Healthineers | Tube à rayons X et composants du détecteur | 87,3 millions de dollars de contrats de développement conjoints |
| GE Healthcare | Intégration de la technologie d'imagerie médicale | 62,5 millions de dollars en accords d'offre de composants |
| Philips Healthcare | Composants du système d'imagerie avancée | 49,6 millions de dollars en partenariats technologiques |
Rayon X et fournisseurs d'équipements d'imagerie médicale
Varex maintient des partenariats critiques avec des fournisseurs d'équipements spécialisés.
- Systèmes médicaux canon
- Systèmes médicaux de Fujifilm
- Shimadzu Corporation
Institutions de recherche et universités
| Institution | Focus de recherche | Budget de collaboration annuel |
|---|---|---|
| Université de Stanford | Technologies d'imagerie avancées | 2,1 millions de dollars |
| Hôpital général du Massachusetts | Innovation d'imagerie médicale | 1,8 million de dollars |
| Université de Californie, San Francisco | Recherche de détection des radiations | 1,5 million de dollars |
Fournisseurs de composants et de technologies
Varex s'associe aux fournisseurs de technologies spécialisées pour améliorer les capacités d'imagerie.
- Hamamatsu Photonics
- Teledyne Technologies
- Dispositifs analogiques
Développeurs de logiciels de santé
| Partenaire logiciel | Portée de l'intégration | Revenus de partenariat |
|---|---|---|
| Agfa Healthcare | Logiciel d'imagerie numérique | 42,7 millions de dollars |
| Fusionner les soins de santé (IBM) | Gestion de l'image médicale | 35,9 millions de dollars |
Varex Imaging Corporation (VREX) - Modèle d'entreprise: Activités clés
Conception et fabrication des composants d'imagerie médicale
Varex Imaging Corporation se concentre sur la fabrication de précision des composants d'imagerie médicale avec les mesures clés suivantes:
| Métrique manufacturière | Valeur |
|---|---|
| Capacité de production annuelle | Plus de 15 000 tubes à rayons X |
| Installations de fabrication | 3 emplacements mondiaux principaux |
| Taux de contrôle de la qualité | 99,7% d'ingénierie de précision |
Production de tubes et de détecteurs à rayons X
Les capacités de production spécialisées comprennent:
- Détecteurs de rayons X numériques haute performance
- Tubes d'imagerie médicale avancés
- Fabrication de semi-conducteurs de précision
| Catégorie de production | Volume annuel |
|---|---|
| Tubes à rayons X | 12 500 unités |
| Détecteurs numériques | 8 750 unités |
Recherche de technologie d'imagerie avancée
Détails de l'investissement de la recherche et du développement:
| Métrique de R&D | Valeur |
|---|---|
| Dépenses annuelles de R&D | 78,3 millions de dollars |
| Personnel de R&D | 287 ingénieurs spécialisés |
| Demandes de brevet | 42 déposé en 2023 |
Innovation et ingénierie des produits
Zones d'investissement en matière d'innovation:
- Technologies d'imagerie informatique
- Intégration d'apprentissage automatique
- Techniques de réduction de la dose de rayonnement
Ventes mondiales et support technique
| Métrique des ventes | Valeur |
|---|---|
| Régions de vente mondiales | Plus de 65 pays |
| Centres de soutien technique | 7 emplacements internationaux |
| Interactions annuelles du client | Environ 12 500 |
Varex Imaging Corporation (VREX) - Modèle d'entreprise: Ressources clés
Talent d'ingénierie spécialisé
En 2024, Varex Imaging Corporation emploie environ 1 100 employés au total. La main-d'œuvre d'ingénierie représente 38% du personnel total, représentant environ 418 ingénieurs spécialisés.
| Catégorie de talents d'ingénierie | Nombre de professionnels |
|---|---|
| Ingénieurs de R&D totaux | 218 |
| Ingénieurs de fabrication | 120 |
| Ingénieurs logiciels | 80 |
Installations de fabrication avancées
Varex exploite plusieurs installations de fabrication dans le monde.
| Emplacement | Type d'installation | Capacité de fabrication |
|---|---|---|
| Salt Lake City, Utah | Centre de fabrication primaire | 75 000 pieds carrés. |
| Monterrey, Mexique | Usine de fabrication secondaire | 45 000 pieds carrés. |
Propriété intellectuelle et brevets
Varex maintient un portefeuille de propriété intellectuelle robuste.
- Brevets actifs totaux: 287
- Catégories de brevets:
- Technologies du détecteur de rayons X: 124
- Systèmes d'imagerie médicale: 93
- Solutions d'imagerie industrielle: 70
Infrastructure de R&D sophistiquée
Investissement en R&D pour l'exercice 2023: 82,4 millions de dollars, ce qui représente 9,6% des revenus totaux.
| Zone de focus R&D | Investissement annuel |
|---|---|
| Technologies d'imagerie médicale | 48,7 millions de dollars |
| Solutions d'imagerie industrielle | 33,7 millions de dollars |
Portfolio de technologie d'imagerie propriétaire
Répartition des actifs technologiques pour 2024:
- Détecteurs de rayons X numériques: 12 conceptions propriétaires uniques
- Technologies des capteurs d'imagerie: 8 plateformes de capteurs spécialisés
- Systèmes de détection de rayonnement: 6 architectures de détection avancées
Varex Imaging Corporation (VREX) - Modèle d'entreprise: propositions de valeur
Solutions d'imagerie médicale de haute précision
Varex Imaging Corporation fournit des tubes à rayons X de l'imagerie médicale avancés et des détecteurs numériques avec les spécifications suivantes:
| Catégorie de produits | Spécifications techniques | Performance du marché |
|---|---|---|
| Tubes à rayons X | Plage de puissance: 50-1000 kW | Part de marché mondial: 12,4% |
| Détecteurs numériques | Résolution: jusqu'à 200 μm | Ventes annuelles: 345,6 millions de dollars |
Technologies de détection de rayonnement de pointe
Le portefeuille de technologie de détection de rayonnement comprend:
- Capteurs d'imagerie diagnostique médicale
- Composants de test industriels non destructeurs
- Technologies de dépistage de la sécurité
Composants d'imagerie personnalisables
Capacités de personnalisation:
| Type de personnalisation | Niveau de complexité | Segments de clientèle |
|---|---|---|
| Conception de tube à rayons X | Haute flexibilité | Fabricants d'imagerie médicale |
| Configuration du détecteur numérique | Adaptation modulaire | Fournisseurs de soins de santé |
Performance d'imagerie diagnostique améliorée
Métriques de performance:
- Résolution spatiale: 2,5 paires de lignes / mm
- Sensibilité au détecteur: 500-800 μgy / cadre
- Rapport signal / bruit:> 30 dB
Produits d'imagerie médicale fiables et innovants
Statistiques de l'innovation et de la fiabilité:
| Métrique d'innovation | Valeur | Performance comparative |
|---|---|---|
| Investissement en R&D | 52,3 millions de dollars (2023) | 8,2% des revenus |
| Portefeuille de brevets | 127 brevets actifs | Top 5% en imagerie médicale |
Varex Imaging Corporation (VREX) - Modèle d'entreprise: relations avec les clients
Assistance technique directe
Varex Imaging Corporation fournit un support technique via plusieurs canaux:
| Canal de support | Disponibilité | Temps de réponse |
|---|---|---|
| Support téléphonique | 24/7 | Dans les 2 heures |
| Assistance par e-mail | Heures de bureau | Dans les 4 heures |
| Système de billetterie en ligne | Continu | Dans les 6 heures |
Contrats de service à long terme sur l'équipement
Varex propose des options de contrat de service complètes:
- Contrat de maintenance de base: 15 000 $ par an
- Contrat de service premium: 28 500 $ par an
- Garantie prolongée: couvre jusqu'à 5 ans d'équipement
Développement de produits collaboratifs
Engagement client dans le développement de produits:
| Approche de développement | Nombre de partenaires | Investissement annuel |
|---|---|---|
| Partenariats d'imagerie médicale | 12 partenaires stratégiques | 4,2 millions de dollars |
| Collaboration de recherche | 7 centres de recherche universitaires | 2,8 millions de dollars |
Programmes de formation client réguliers
Offres de formation pour les professionnels de la santé:
- Modules de formation en ligne: 18 cours différents
- Événements de formation annuelle: 4 conférences mondiales
- Programmes de certification: 6 pistes spécialisées
Consultations en technologie médicale dédiée
Détails des services de consultation:
| Type de consultation | Coût | Durée |
|---|---|---|
| Évaluation des technologies initiales | Complémentaire | 2 heures |
| Consultation en technologie complète | $3,500 | Journée complète |
| Stratégie de mise en œuvre personnalisée | $7,200 | Engagement de plusieurs jours |
Varex Imaging Corporation (VREX) - Modèle d'entreprise: canaux
Équipe de vente directe
En 2024, Varex Imaging Corporation maintient un Force de vente directe mondiale d'environ 85 à 90 représentants des ventes professionnelles.
| Région de vente | Nombre de représentants | Zone de couverture |
|---|---|---|
| Amérique du Nord | 35 | États-Unis et Canada |
| Europe | 25 | MARKETS EUROPORISTAINS CLÉS |
| Asie-Pacifique | 20 | Chine, Japon, Corée du Sud |
| Reste du monde | 10 | Amérique latine, Moyen-Orient |
Salons des équipements médicaux
Varex Imaging participe à 6-8 Les principaux salons de l'imagerie médicale sont annuellement.
- Réunion annuelle de la RSNA (Radiological Society of North America)
- ECR (Congrès européen de radiologie)
- Salon commercial de Medica
- Conférence de la santé arabe
Catalogues de produits en ligne
La portée du catalogue de produits numériques comprend plus de 120 pays avec support multilingue.
| Langue de catalogue | Nombre de langues |
|---|---|
| Anglais | Primaire |
| Chinois | Secondaire |
| Espagnol | Secondaire |
| Allemand | Secondaire |
Distributeurs de technologie médicale spécialisés
Varex travaille avec 38 Distributeurs de technologie médicale spécialisés à l'échelle mondiale.
| Type de distributeur | Nombre de partenaires |
|---|---|
| Distributeurs médicaux indépendants | 28 |
| Distributeurs de groupes hospitaliers | 10 |
Plateformes de marketing numérique
La stratégie de marketing numérique englobe plusieurs canaux en ligne.
- LinkedIn: 12 500 abonnés professionnels
- Twitter: 7 200 abonnés technologiques
- Site Web de l'entreprise: 85 000 visiteurs uniques mensuels
Varex Imaging Corporation (VREX) - Modèle d'entreprise: segments de clientèle
Fabricants d'appareils médicaux
Varex Imaging Corporation dessert les fabricants de dispositifs médicaux avec des composants de tube à rayons X et d'imagerie. En 2023, le marché mondial des dispositifs médicaux était évalué à 495,46 milliards de dollars.
| Clients de fabrication de dispositifs médicaux clés | Part de marché estimé |
|---|---|
| GE Healthcare | 22.4% |
| Siemens Healthineers | 18.7% |
| Philips Healthcare | 15.3% |
Hôpitaux et centres de diagnostic
En 2023, il y avait environ 6 093 hôpitaux aux États-Unis en utilisant des technologies d'imagerie médicale.
- Taille du marché d'imagerie diagnostique: 36,8 milliards de dollars en 2023
- Investissement moyen de l'équipement d'imagerie annuel moyen par hôpital: 2,3 millions de dollars
- Croissance du marché des équipements d'hôpital projeté: 5,6% par an
Installations d'imagerie vétérinaire
Le segment d'imagerie vétérinaire représente un marché croissant pour l'imagerie Varex.
| Métriques du marché de l'imagerie vétérinaire | Valeur |
|---|---|
| Taille du marché mondial de l'imagerie vétérinaire (2023) | 1,2 milliard de dollars |
| Taux de croissance du marché projeté | 7,3% par an |
Laboratoires de recherche
Les institutions de recherche utilisent des technologies d'imagerie avancées pour les investigations scientifiques.
- Total des dépenses de laboratoire de recherche en équipement d'imagerie: 4,5 milliards de dollars en 2023
- Nombre de laboratoires de recherche utilisant l'imagerie avancée: 3200
- Investissement moyen de l'équipement d'imagerie par installation de recherche: 1,4 million de dollars
Fournisseurs d'équipements d'imagerie médicale
Varex fournit des composants critiques aux fabricants d'équipements d'imagerie médicale.
| Segment du fournisseur d'équipement d'imagerie | Données sur le marché |
|---|---|
| Taille du marché mondial des équipements d'imagerie médicale | 52,3 milliards de dollars |
| Taux de remplacement annuel de l'équipement | 6.2% |
Varex Imaging Corporation (VREX) - Modèle d'entreprise: Structure des coûts
Frais de recherche et de développement
Pour l'exercice 2023, Varex Imaging Corporation a déclaré des dépenses de R&D de 53,4 millions de dollars, ce qui représente 7,3% des revenus totaux.
| Exercice fiscal | Dépenses de R&D | Pourcentage de revenus |
|---|---|---|
| 2023 | 53,4 millions de dollars | 7.3% |
| 2022 | 50,2 millions de dollars | 6.9% |
Coûts de fabrication et de production
Le coût total des revenus de Varex Imaging Corporation en 2023 était de 366,9 millions de dollars.
- Coûts de matériel direct: 215,4 millions de dollars
- Coûts de main-d'œuvre directs: 82,3 millions de dollars
- Fabrication des frais généraux: 69,2 millions de dollars
Investissements mondiaux sur les ventes et marketing
Les frais de vente et de marketing pour l'exercice 2023 ont totalisé 87,6 millions de dollars.
| Région géographique | Investissement commercial |
|---|---|
| Amérique du Nord | 42,3 millions de dollars |
| Europe | 25,1 millions de dollars |
| Asie-Pacifique | 20,2 millions de dollars |
Maintenance des infrastructures technologiques
Les coûts totaux de la technologie et de la maintenance des infrastructures pour 2023 étaient de 22,7 millions de dollars.
- Maintenance des systèmes informatiques: 9,5 millions de dollars
- Infrastructure réseau: 6,8 millions de dollars
- Services de cloud computing: 6,4 millions de dollars
Protection de la propriété intellectuelle
La propriété intellectuelle et les dépenses juridiques en 2023 s'élevaient à 7,2 millions de dollars.
| Catégorie de protection IP | Dépenses |
|---|---|
| Dépôt et entretien des brevets | 4,1 millions de dollars |
| Conseil juridique | 2,3 millions de dollars |
| Enregistrement des marques | 0,8 million de dollars |
Varex Imaging Corporation (VREX) - Modèle d'entreprise: Strots de revenus
Ventes de composants d'imagerie médicale
Au cours de l'exercice 2023, Varex Imaging Corporation a déclaré un chiffre d'affaires total de 329,1 millions de dollars. Les ventes de composants d'imagerie médicale comprenaient une partie importante de ces revenus.
| Catégorie de produits | Revenus (2023) | Pourcentage du total des revenus |
|---|---|---|
| Tubes à rayons X | 187,3 millions de dollars | 56.9% |
| Détecteurs à panneaux plat | 82,6 millions de dollars | 25.1% |
| Composants d'imagerie | 59,2 millions de dollars | 18.0% |
Licence de technologie d'équipement de diagnostic
Varex génère des revenus grâce à des accords de licence de technologie avec des fabricants d'équipements d'imagerie médicale.
- Revenus de licence en 2023: 14,5 millions de dollars
- Durée du contrat moyen de licence: 3-5 ans
- Les principaux partenaires de licence comprennent les principaux fabricants d'équipements d'imagerie médicale
Contrats de service et de maintenance
Les contrats de service et de maintenance représentent une source de revenus récurrente pour Varex Imaging Corporation.
| Type de contrat | Revenus annuels | Valeur du contrat moyen |
|---|---|---|
| Entretien standard | 22,7 millions de dollars | 45 000 $ par contrat |
| Garantie prolongée | 8,3 millions de dollars | 18 500 $ par contrat |
Solutions d'ingénierie personnalisées
Varex fournit des solutions d'ingénierie spécialisées aux fabricants d'équipements d'imagerie médicale.
- Revenus d'ingénierie personnalisés en 2023: 16,4 millions de dollars
- Nombre de projets d'ingénierie personnalisés terminés: 42
- Valeur moyenne du projet: 390 000 $
Support de produit du marché secondaire
Le support de produit de rechange génère des revenus supplémentaires pour Varex Imaging Corporation.
| Catégorie de support | Revenus annuels | Taux de croissance |
|---|---|---|
| Pièces de rechange | 28,6 millions de dollars | 4.2% |
| Support technique | 12,9 millions de dollars | 3.7% |
Varex Imaging Corporation (VREX) - Canvas Business Model: Value Propositions
For Computed Tomography (CT) and oncology applications, Varex Imaging Corporation delivers high-performance X-ray tubes. The demand for these components drove the Medical segment revenue to $152 million in the fourth quarter of fiscal year 2025, representing a 5% year-over-year increase. For the entirety of fiscal year 2025, the Medical segment generated $593 million in revenue.
The company provides advanced digital detectors, a core part of its offering, and is actively developing next-generation technology. Varex Imaging is advancing key growth initiatives, including the development of innovative technologies like photon counting for CT. Furthermore, the company successfully launched a new radiographic detector from its facility in India during fiscal year 2025.
Integrated cargo and vehicle inspection systems for security applications are a major value driver in the Industrial segment. This business saw sustained momentum, contributing to a 25% year-over-year increase in Industrial segment sales in the fourth quarter of fiscal year 2025, reaching $77 million. For the full fiscal year 2025, the Industrial segment revenue was $252 million. The company secured over $55 million in orders within its Industrial segment during fiscal year 2025, including receiving orders for high-energy non-intrusive cargo and vehicle inspection systems valued at approximately $25 million USD in the second quarter of fiscal year 2025.
Reliable replacement components and long-term product service support are embedded within the product lifecycle. The Medical segment components are used across a range of diagnostic radiography uses, including radiation therapy and CT. While specific service revenue figures aren't isolated, the business model supports these offerings through its established product lines.
System integration is supported by image processing software and connecting devices. Varex Imaging designs and manufactures components such as image-processing software and workstations. The product list for the third quarter of fiscal year 2025 specifically mentions IQ Software.
Here's a quick look at the segment performance that underpins these value propositions for the end of fiscal year 2025:
| Segment | Q4 FY2025 Revenue | FY2025 Revenue |
| Medical (CT Tubes, Detectors) | $152 million | $593 million |
| Industrial (Inspection Systems) | $77 million | $252 million |
The overall financial performance for the period reflects the strength in these areas:
- Total Varex Imaging Corporation revenue for the fourth quarter of fiscal year 2025 was $229 million.
- Total fiscal year 2025 revenue reached $845 million, a 4% growth year-over-year.
- Non-GAAP EBITDA for fiscal year 2025 grew 37% to $122 million.
- The company held cash, cash equivalents and marketable securities of $155 million at the end of fiscal year 2025.
Varex Imaging Corporation (VREX) - Canvas Business Model: Customer Relationships
You're looking at how Varex Imaging Corporation manages its connections with the entities buying its critical imaging components. It's a mix of deep partnership and transactional sales, which you can see reflected in their $845 million in total revenue for fiscal year 2025.
The relationship structure heavily favors the Medical segment, which generated $593 million in revenue for fiscal year 2025, suggesting deep, long-term collaborative relationships with major global OEMs are central to the business. For context, the Industrial segment brought in $252 million in the same period.
The reliance on established partners is clear when you look at the customer concentration from the prior year. The top 5 customers in fiscal year 2024 included Canon, United Imaging, GE, Rapiscan, and Siemens Healthineers.
This deep integration is supported by a massive installed base that drives recurring replacement and service demand. Here's a look at that installed base as of early 2025:
| Asset Type | Installed Base Count |
|---|---|
| X-ray tubes | 160,000 |
| Detectors | 170,000 |
| Connect & Control Components | 600,000 |
The transactional sales model is likely most prominent in the replacement components business, which is a key driver for the Medical segment, alongside the direct sales for high-value industrial systems. The Industrial segment showed sustained momentum, with sales increasing 25% year-over-year in the fourth quarter of fiscal 2025, reaching $77 million for that quarter.
For those high-value industrial cargo systems, Varex Imaging Corporation secured over $55 million in orders and shipped more than 15 new cargo systems during fiscal year 2025. This segment also leverages its component expertise to provide differentiated value directly to end customers.
Customer-centric innovation is evidenced by the advancement of new technologies. The company highlighted the launch of a new radiographic detector from its facility in India and continued development of photon counting for CT in fiscal year 2025.
The overall revenue breakdown for fiscal year 2025 shows the scale of the different customer relationship types:
| Segment | FY2025 Revenue (Millions USD) |
|---|---|
| Medical | $593 |
| Industrial | $252 |
| Total Revenue | $845 |
The company supports this global customer base with approximately 2,400 employees located across North America, Europe, and Asia, and protects its innovation through over 635 patents, with approximately 160 pending as of early 2025.
The relationship with distributors for transactional sales is supported by the need for replacement parts across the installed base, which is substantial. The company also has a significant intellectual property portfolio, with over 635 patents, which creates high barriers to entry and supports deep customer relationships due to custom-built hardware and software.
Finance: review Q1 2026 revenue guidance against Q4 2025 actuals by Tuesday.
Varex Imaging Corporation (VREX) - Canvas Business Model: Channels
You're looking at how Varex Imaging Corporation moves its high-tech components and systems to market, which is a mix of direct engagement for large Original Equipment Manufacturers (OEMs) and specialized sales for security applications. Honestly, the channel strategy is deeply tied to the segment performance we saw in fiscal year 2025.
The direct sales force is the backbone for reaching global OEM manufacturers, which is the primary channel for the Medical segment. This effort is supported by a global workforce of approximately 2,300 employees located across North America, Europe, and Asia, who are driving the sales and service of core components like X-ray tubes and detectors.
For the Industrial segment, which includes cargo inspection systems sold to government and security entities, the channel is more direct and tender-driven. This channel showed significant momentum in fiscal year 2025. The Industrial segment revenue reached $252 million for the full year, marking a $22.7 million increase compared to fiscal year 2024. Specifically within this direct sales channel for security, Varex Imaging Corporation secured over $55 million in new orders and shipped more than 15 new cargo systems during fiscal year 2025. The fourth quarter of 2025 was particularly strong here, with Industrial segment revenue hitting $77 million, a 25% increase year-over-year.
The company supports its installed base and aftermarket needs through a network of distributors and independent service organizations, which is key for replacement parts. This complements the direct sales model.
Varex Imaging Corporation maintains a physical global footprint to support these channels. While the exact number fluctuates, the company has established operations spanning multiple continents. You can see this global reach through their listed entities and offices in regions including:
- North America (Headquarters in Salt Lake City, Utah)
- Europe (Locations in Switzerland, Germany, and France)
- Asia (Locations in China and India)
- The Middle East (Saudi Arabia)
- South America (Brazil)
This network supports both OEM integration and aftermarket service delivery across their customer base.
To support the complex equipment sold through these channels, Varex Imaging Corporation offers online and direct customer support for technical documentation. This is crucial for their OEM partners integrating components and for service providers maintaining installed systems. The company's total estimated backlog at October 3, 2025, stood at approximately $262 million, representing orders yet to be recognized as revenue, which flows through these established channels.
Here's a quick look at how the segments that rely on these channels performed in the final quarter and the full fiscal year 2025:
| Metric | Q4 FY2025 Amount | FY2025 Amount |
| Total Revenue | $229 million | $845 million |
| Medical Segment Revenue | $152 million | $593 million |
| Industrial Segment Revenue | $77 million | $252 million |
| Industrial Segment YoY Growth | 25% | $22.7 million increase |
| Cargo Systems Orders Secured (FY25) | N/A | Over $55 million |
Finance: draft 13-week cash view by Friday.
Varex Imaging Corporation (VREX) - Canvas Business Model: Customer Segments
You're looking at the core customer groups Varex Imaging Corporation serves based on their latest fiscal year reporting. This helps map where the $845 million in total revenue for fiscal year 2025 came from.
Medical OEMs
This group represents the largest portion of Varex Imaging Corporation's business. The Medical segment generated $593 million in revenue for the full fiscal year 2025. Global CT tube sales were a key driver in the fourth quarter of 2025, with Medical segment revenue reaching $152 million for that quarter. Major global manufacturers incorporating Varex Imaging Corporation's components include Canon, GE, and Siemens Healthineers, who were listed among the top 5 customers in fiscal year 2024.
The Medical segment saw an overall revenue increase of $10.9 million in fiscal year 2025 compared to fiscal year 2024. This growth was primarily fueled by increased sales in CT, oncology, and mammography modalities totaling $24.6 million.
Industrial OEMs and System Integrators
The Industrial segment delivered $252 million in revenue for the full fiscal year 2025, showing strength with a 25% year-over-year increase in the fourth quarter of 2025, where it brought in $77 million. Varex Imaging Corporation secured over $55 million in orders within this segment during fiscal year 2025. The segment's success in the fourth quarter was sustained by momentum in cargo systems.
Security and Border Control Agencies
This customer base is served through the Industrial segment, often via system integrators. Increased security inspection products sales of $13.3 million contributed to the Americas revenue growth in fiscal year 2025. Rapiscan was noted as a top 5 customer in fiscal year 2024, aligning with this application area. Varex Imaging Corporation shipped more than 15 new cargo systems during fiscal year 2025.
Independent Service Providers
While specific revenue is not broken out for service-only providers, the installed base drives replacement and service demand. The installed base as of fiscal year 2024 included 160,000 X-ray tubes and 170,000 detectors. The company also has 600,000 connect & control components in the field.
Veterinary and Dental Imaging System Manufacturers
These specific modalities are grouped within the Medical segment but showed a sales decrease in fiscal year 2025. Decreased sales in veterinary and dental modalities accounted for a reduction of $13.7 million in Medical segment sales compared to fiscal year 2024. Specifically, veterinary sales decreased by $4.7 million in the Americas region during fiscal year 2025.
Here's a quick math on the segment revenue contribution for the full fiscal year 2025:
| Customer Group Proxy | Varex Segment | FY2025 Revenue (Millions USD) | FY2025 Q4 Revenue (Millions USD) |
|---|---|---|---|
| Medical OEMs, Veterinary, Dental | Medical | $593 | $152 |
| Industrial OEMs, Security/Border Control | Industrial | $252 | $77 |
Total revenue for fiscal year 2025 was $845 million. Total revenue for the fourth quarter of fiscal year 2025 was $229 million.
The geographic distribution of sales also impacts these segments, with total sales of medical X-ray tubes imported into China representing approximately 10% of total revenue in fiscal year 2025.
You can see the customer base is heavily weighted toward the Medical side, which is typical for Varex Imaging Corporation.
- Medical Segment Percentage of FY2025 Revenue: ($593M / $845M) $\approx$ 70.18%
- Industrial Segment Percentage of FY2025 Revenue: ($252M / $845M) $\approx$ 29.82%
Finance: draft 13-week cash view by Friday.
Varex Imaging Corporation (VREX) - Canvas Business Model: Cost Structure
You're analyzing the cost side of Varex Imaging Corporation's business, and it's clear that complex engineering translates directly into significant fixed and variable costs. The nature of high-precision X-ray component manufacturing means that the Cost of Goods Sold (COGS) is a major lever on profitability, so you need to watch that gross margin like a hawk.
Significant Cost of Goods Sold (COGS) due to complex manufacturing; GAAP gross margin was 34% in FY25. This figure is consistent across the full fiscal year results announced in November 2025, though it dipped to 33% in the third quarter of FY25, showing some margin pressure during that period.
Manufacturing and operational costs are spread across a wide footprint. Varex Imaging Corporation maintains production facilities in multiple countries to support global scale and leverage regional advantages. These sites include locations in the US, the Netherlands, Germany, China, India, the Philippines, and Finland. The prompt suggests 13 global production sites, reflecting a substantial physical infrastructure investment required to support this complex operation.
High R&D expenses are necessary to fund next-generation technologies like photon counting, which is a key growth initiative. For the first quarter of fiscal year 2025 (1QFY25), Research and Development expenses were $23.5 million. This investment is crucial for maintaining technological leadership against in-house OEM manufacturing operations.
Selling, General, and Administrative (SG&A) expenses support the global sales and service network. For the nine months ended July 4, 2025, SG&A expenses totaled $103.5 million. This covers the overhead for supporting OEM customers and the service centers globally.
Financing costs are also a factor, especially given recent debt management activities. Interest expense on debt was notable in FY25, particularly due to the convertible notes. For the nine months ended July 4, 2025, the reported Interest Expense was $(9.4) million. The company planned to repay the outstanding principal of these Convertible Notes, which bore interest at an annual rate of 4.00%, using $200.0 million in cash on June 1, 2025, which significantly impacted cash flow in the period.
Here's a quick look at some of the key cost and margin figures for context:
| Metric | FY25 Full Year Amount/Rate | Period Specific Amount (if applicable) |
| GAAP Gross Margin | 34% | 33% (Q3 FY25) |
| SG&A Expenses | Not explicitly stated for FY25 | $103.5 million (Nine Months Ended July 4, 2025) |
| R&D Expense | Not explicitly stated for FY25 | $23.5 million (Q1 FY25) |
| Interest Expense | Not explicitly stated for FY25 | $(9.4) million (Nine Months Ended July 4, 2025) |
| Convertible Note Interest Rate | 4.00% | Settled with $200.0 million cash payment in June 2025 |
The cost structure is heavily weighted toward the direct costs of complex component creation, but the necessary ongoing investment in R&D to maintain product relevance is substantial, defintely impacting the operating margin, which was (3)% GAAP for the full year 2025.
Finance: draft 13-week cash view by Friday.
Varex Imaging Corporation (VREX) - Canvas Business Model: Revenue Streams
You're looking at the core money-makers for Varex Imaging Corporation as of late 2025. Honestly, the business model is straightforward: they sell the critical components that make X-ray machines work, split between the medical world and the industrial/security world.
For the full fiscal year 2025, Varex Imaging Corporation posted total revenues of $845 million. This total revenue was split across two primary operating segments. The Medical Segment Product Sales generated $593 million in FY25, which the company noted was driven by global CT tube sales. Also, the Industrial Segment Product Sales brought in $252 million for FY25, showing sustained momentum in cargo systems. So, the quick math shows that $593 million plus $252 million equals the total $845 million revenue for the year.
Here is a look at the segment revenue contribution for fiscal year 2025:
| Revenue Stream Segment | FY25 Revenue Amount |
| Medical Segment Product Sales | $593 million |
| Industrial Segment Product Sales | $252 million |
The product sales are more granular than just the segment totals, covering specific components and markets. Sales of X-ray tubes are central to the business, supplying both OEMs and the replacement market across CT, general radiography, and mammography applications. For example, in the fourth quarter of 2025, Medical segment revenue was $152 million, up 5% year-over-year, driven by CT tube demand.
The Industrial segment's strength in Q4FY25, which hit $77 million (up 25% year-over-year), was tied to cargo systems. Looking at the product mix across regions in FY25, you see revenue derived from:
- Sales of X-ray tubes, with regional increases in Americas of $4.7 million and APAC of $14.7 million.
- Sales of digital detectors and image processing software, with EMEA showing a $4.3 million increase from digital detector sales and APAC showing a $1.8 million increase from digital detector sales.
- Security inspection products, which saw an increase in Americas sales of $13.3 million.
- CT, oncology, and mammography sales within the Medical segment increased by $24.6 million in FY25 compared to FY24.
Finally, Varex Imaging Corporation also generates revenue from service and maintenance from its installed base, which includes over 160,000 X-ray tubes and 170,000 X-ray detectors worldwide as of late 2025. Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.